Recall | Medicines | 15/03/2012

The marketing authorization holder informed its supplied customers in a letter dated March 15, 2012, that a degradation product of the active ingredient cinchocaine hydrochloride exceeded the specification limit during the period of use and that a recall must therefore be carried out.

Name of the medicinal product Scheriproct – Salbe 30g
Marketing authorisation number(s) 10260
Marketing authorisation holder Bayer Austria GmbH
Batch number(s) 94081A, 02108A, 11149B, 13174C
Expiry date 09/04/2019
Classification of the recall2
BASG reference number INS-640.001-0385

Further inquiry note